Food and Drug Administration Likely to Tighten Controls on Hydrocodone Combination Drugs
The Health Law Firm
JANUARY 31, 2013
By Lance O. Leider, J.D., The Health Law Firm, and George F. Indest III, J.D., M.P.A., LL.M., Board Certified by The Florida Bar in Health Law. A Food and Drug Administration (FDA) advisory committee voted 19 to 10 in favor of moving hydrocodone combination drugs from schedule III into the more restrictive schedule II category of controlled substances.
Let's personalize your content